Work

The Clinical Presentation of Thrombotic Microangiopathy

Year: 2025

Type: article

Abstract: Thrombotic microangiopathy (TMA) is characterized by thrombocytopenia, microangiopathic haemolytic anaemia and end organ damage. Microangiopathic haemolytic anaemia is caused by red blood cell fragmentation in the microvasculature, with schistocytes seen on peripheral blood film. Lactate dehydrogenase (LDH) is raised due to tissue ischemia and cell lysis. Low plasma haptoglobin is a marker of haemolysis as it binds to free haemoglobin and the complex is cleared by macrophages. Coombs test is gener negative. Renal involvement is common to most TMAs due to its vulnerability to occlusion and endothelial damage.

Source: International Journal of Pharmaceutical and Bio-Medical Science

DOI: 10.47191/ijpbms/v5-i3-10

Authors: Guliko Kiliptari, Nino Agladze

Institutions: Tbilisi State Medical University, Tbilisi State University

Language: English

Topic: Complement system in diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4408997321

FWCI:

Cites:

Cited by:

Related to: 10